Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in CashFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Goldenwell Biotech (GWLL) Change in Account Payables (2021 - 2022)

Goldenwell Biotech's Change in Account Payables history spans 2 years, with the latest figure at -$111488.0 for Q3 2022.

  • For Q3 2022, Change in Account Payables changed N/A year-over-year to -$111488.0; the TTM value through Mar 2024 reached -$111488.0, changed 0.0%, while the annual FY2022 figure was -$111488.0, 200.0% down from the prior year.
  • Change in Account Payables reached -$111488.0 in Q3 2022 per GWLL's latest filing, roughly flat from -$111488.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $8363.0 in Q4 2021 to a low of -$111488.0 in Q1 2022.